M. Deininger, S. G. O’Brien, F. Guilhot, J. M. Goldman, A. Hochhaus and T. P. Hughes, “International Rando-mized Study of Interferon versus STI571 (IRIS) 8-Year Follow-Up: Sustained Survival and Low Risk for Pro-gression or Events in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Imatinib,” Blood (ASH Annual Meeting Ab-stracts), Vol. 114, 2009, p. 1126.

has been cited by the following article:

• TITLE: Diagnosis of Chronic Myeloid Leukemia Early in Pregnancy

  AUTHORS: Fabio Stagno, Paolo Vigneri, Massimo Poidomani, Stefania Stella, Alessandra Cupri, Michele Massimino, Livia Manzella, Francesco Di Raimondo

  KEYWORDS: Chronic Myeloid Leukemia, Pregnancy, Therapy, BCR-ABL

  JOURNAL NAME: Open Journal of Blood Diseases, Vol.1 No.1, September 20, 2011

  ABSTRACT: Imatinib therapy has revolutionized the clinical course of Chronic Myeloid Leukemia. The unexpected prolonged survival raised several issues on the quality of life and on the possibility to parent childs.